Treace Medical Concepts Inc (NASDAQ:TMCI) Stock Plummets 27% After Slashing 2025 Revenue Outlookchartmill.comTreace Medical's Q3 2025 results missed revenue estimates. Shares plunged 27% after the company slashed its full-year sales and EBITDA guidance.
What's going on in today's after hours sessionchartmill.comDiscover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Curious about the stocks that are showing activity after the closing bell on Thursday?chartmill.comWondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Get insights into the top gainers and losers of Friday's pre-market session.chartmill.comDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
